Skip to main content
Top
Published in: Archives of Virology 10/2016

01-10-2016 | Original Article

Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys

Authors: Yan-Dong Tang, Xiang Zhang, Lei Na, Xue-feng Wang, Li-Hua Fu, Chun-Hui Zhu, Xiaojun Wang, Jian-Hua Zhou

Published in: Archives of Virology | Issue 10/2016

Login to get access

Abstract

Equine infectious anemia virus (EIAV) is a member of the genus Lentivirus of the family Retroviridae. Horses are the most susceptible equids to EIAV infection and are therefore the primary hosts of this virus. In contrast, infected donkeys do not develop clinically active equine infectious anemia (EIA). This phenomenon is similar to what has been observed with HIV-1, which fails to induce AIDS in non-human primates. Interestingly, Shen et al. developed a donkey-tropic pathogenic virus strain (EIAVDV117, DV117) by serially passaging a horse-tropic pathogenic strain, EIAVLN40 (LN40), in donkeys. LN40, which was generated by passaging a field isolate in horses, displayed enhanced virulence in horses but caused no clinical symptoms in donkeys. Infection with DV117 induced acute EIA in nearly 100 % of donkeys. Genomic analysis of DV117 revealed a significantly higher frequency of A-to-G substitutions when compared to LN40. Furthermore, detailed analysis of dinucleotide editing showed that A-to-G mutations had a preference for 5’TpA and 5’ApA. These results strongly implicated the activity of the adenosine deaminase, ADAR1, in this type of mutation. Further investigation demonstrated that overexpression of donkey ADAR1 increased A-to-G mutations within the genome of EIAV. Together with our previous finding that multiple mutations in multiple genes are generated in DV117 during its adaptation from horses to donkeys, the present study suggests that ADAR1-induced A-to-G mutations occur during virus adaption to related new hosts contributing to the alteration of EIAV host tropism.
Literature
1.
4.
go back to reference Doria M, Neri F, Gallo A, Farace MG, Michienzi A (2009) Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res 37:5848–5858CrossRefPubMedPubMedCentral Doria M, Neri F, Gallo A, Farace MG, Michienzi A (2009) Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res 37:5848–5858CrossRefPubMedPubMedCentral
5.
go back to reference Suspene R, Petit V, Puyraimond-Zemmour D, Aynaud MM, Henry M, Guetard D, Rusniok C, Wain-Hobson S, Vartanian JP (2011) Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol 85:2458–2462CrossRefPubMed Suspene R, Petit V, Puyraimond-Zemmour D, Aynaud MM, Henry M, Guetard D, Rusniok C, Wain-Hobson S, Vartanian JP (2011) Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol 85:2458–2462CrossRefPubMed
6.
go back to reference Ko NL, Birlouez E, Wain-Hobson S, Mahieux R, Vartanian JP (2012) Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1. J General Virol 93:2646–2651CrossRef Ko NL, Birlouez E, Wain-Hobson S, Mahieux R, Vartanian JP (2012) Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1. J General Virol 93:2646–2651CrossRef
7.
go back to reference Leroux C, Cadore JL, Montelaro RC (2004) Equine infectious anemia virus (EIAV): what has HIV’s country cousin got to tell us? Vet Res 35:485–512CrossRefPubMed Leroux C, Cadore JL, Montelaro RC (2004) Equine infectious anemia virus (EIAV): what has HIV’s country cousin got to tell us? Vet Res 35:485–512CrossRefPubMed
8.
go back to reference Cook SJ, Cook RF, Montelaro RC, Issel CJ (2001) Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus. Vet Microbiol 79:93–109CrossRefPubMed Cook SJ, Cook RF, Montelaro RC, Issel CJ (2001) Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus. Vet Microbiol 79:93–109CrossRefPubMed
9.
go back to reference Feng JL (1997) Equine infectious anemia and its controlling in China, a document issued by the Chinese Ministry of Agriculture in 1997 (In Chinese) Feng JL (1997) Equine infectious anemia and its controlling in China, a document issued by the Chinese Ministry of Agriculture in 1997 (In Chinese)
10.
go back to reference Shen RX, Xu Z, He YS, Zhang SX (1979) Development of a EIAV donkey leucocyte attenuated vaccine. China Agric Sci 4:1–15 Shen RX, Xu Z, He YS, Zhang SX (1979) Development of a EIAV donkey leucocyte attenuated vaccine. China Agric Sci 4:1–15
11.
go back to reference Tang YD, Na L, Fu LH, Yang F, Zhu CH, Tang L, Li Q, Wang JY, Li Z, Wang XF, Li CY, Wang X, Zhou JH (2015) Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity. Virology 476:364–371CrossRefPubMed Tang YD, Na L, Fu LH, Yang F, Zhu CH, Tang L, Li Q, Wang JY, Li Z, Wang XF, Li CY, Wang X, Zhou JH (2015) Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity. Virology 476:364–371CrossRefPubMed
12.
go back to reference Qi X, Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Shen R, Wang F, Kong X, Su Z, Zhou J (2010) Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13. Virus Genes 41:86–98CrossRefPubMed Qi X, Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Shen R, Wang F, Kong X, Su Z, Zhou J (2010) Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13. Virus Genes 41:86–98CrossRefPubMed
13.
go back to reference Wang XF, Lin YZ, Li Q, Liu Q, Zhao WW, Du C, Chen J, Wang X, Zhou JH (2016) Genetic evolution during the development of an attenuated EIAV vaccine. Retrovirology 13:9CrossRefPubMedPubMedCentral Wang XF, Lin YZ, Li Q, Liu Q, Zhao WW, Du C, Chen J, Wang X, Zhou JH (2016) Genetic evolution during the development of an attenuated EIAV vaccine. Retrovirology 13:9CrossRefPubMedPubMedCentral
14.
go back to reference Lin YZ, Cao XZ, Li L, Jiang CG, Wang XF, Ma J, Zhou JH (2011) The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages. Virus Res 160:274–282CrossRefPubMed Lin YZ, Cao XZ, Li L, Jiang CG, Wang XF, Ma J, Zhou JH (2011) The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages. Virus Res 160:274–282CrossRefPubMed
15.
go back to reference Tang YD, Na L, Zhu CH, Shen N, Yang F, Fu XQ, Wang YH, Fu LH, Wang JY, Lin YZ, Wang XF, Wang X, Zhou JH, Li CY (2014) Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum. J Virol 88:12296–12310CrossRefPubMedPubMedCentral Tang YD, Na L, Zhu CH, Shen N, Yang F, Fu XQ, Wang YH, Fu LH, Wang JY, Lin YZ, Wang XF, Wang X, Zhou JH, Li CY (2014) Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum. J Virol 88:12296–12310CrossRefPubMedPubMedCentral
16.
go back to reference Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Kong X, Zhou J (2011) Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains. Arch Virol 156:353–357CrossRefPubMed Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Kong X, Zhou J (2011) Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains. Arch Virol 156:353–357CrossRefPubMed
17.
go back to reference Heeney J, Bogers W, Buijs L, Dubbes R, ten Haaft P, Koornstra W, Niphuis H, Nara P, Teeuwsen V (1996) Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol Lett 51:45–52CrossRefPubMed Heeney J, Bogers W, Buijs L, Dubbes R, ten Haaft P, Koornstra W, Niphuis H, Nara P, Teeuwsen V (1996) Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol Lett 51:45–52CrossRefPubMed
18.
go back to reference Cranage MP, Cook N, Stott EJ, Cook R, Baskerville A, Greenaway PJ (1992) Transmission studies with simian immunodeficiency virus of macaques; persistent infection of baboons. Intervirology 34:53–61PubMed Cranage MP, Cook N, Stott EJ, Cook R, Baskerville A, Greenaway PJ (1992) Transmission studies with simian immunodeficiency virus of macaques; persistent infection of baboons. Intervirology 34:53–61PubMed
19.
go back to reference Ten Haaft P, Verstrepen B, Uberla K, Rosenwirth B, Heeney J (1998) A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol 72:10281–10285PubMedPubMedCentral Ten Haaft P, Verstrepen B, Uberla K, Rosenwirth B, Heeney J (1998) A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol 72:10281–10285PubMedPubMedCentral
20.
go back to reference Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167–1170CrossRefPubMed Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167–1170CrossRefPubMed
21.
go back to reference Gutierrez RA, Viari A, Godelle B, Frutos R, Buchy P (2013) Biased mutational pattern and quasispecies hypothesis in H5N1 virus. Infect Genet Evolut J Mol Epidemiol Evolut Genet Infect Dis 15:69–76CrossRef Gutierrez RA, Viari A, Godelle B, Frutos R, Buchy P (2013) Biased mutational pattern and quasispecies hypothesis in H5N1 virus. Infect Genet Evolut J Mol Epidemiol Evolut Genet Infect Dis 15:69–76CrossRef
22.
go back to reference Suspene R, Renard M, Henry M, Guetard D, Puyraimond-Zemmour D, Billecocq A, Bouloy M, Tangy F, Vartanian JP, Wain-Hobson S (2008) Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res 36:e72CrossRefPubMedPubMedCentral Suspene R, Renard M, Henry M, Guetard D, Puyraimond-Zemmour D, Billecocq A, Bouloy M, Tangy F, Vartanian JP, Wain-Hobson S (2008) Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res 36:e72CrossRefPubMedPubMedCentral
23.
go back to reference Lee JH, Culver G, Carpenter S, Dobbs D (2008) Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV. PloS One 3:e2272CrossRefPubMedPubMedCentral Lee JH, Culver G, Carpenter S, Dobbs D (2008) Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV. PloS One 3:e2272CrossRefPubMedPubMedCentral
24.
go back to reference Scadden AD (2005) The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat Struct Mol Biol 12:489–496CrossRefPubMed Scadden AD (2005) The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat Struct Mol Biol 12:489–496CrossRefPubMed
Metadata
Title
Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys
Authors
Yan-Dong Tang
Xiang Zhang
Lei Na
Xue-feng Wang
Li-Hua Fu
Chun-Hui Zhu
Xiaojun Wang
Jian-Hua Zhou
Publication date
01-10-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-2951-3

Other articles of this Issue 10/2016

Archives of Virology 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.